Please login to the form below
AZ divests European rights for cholesterol med Crestor to Grünenthal
Grünenthal will pay up to $350m for the rights
Moderna eyes COVID-19 vaccine approval in the US and the EU
Updated analysis demonstrates vaccine efficacy of 94.1%
AZ, Oxford University face more scrutiny over COVID-19 vaccine data
WHO’s immunisations director says ‘more than a press release’ is needed
Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda
Trial will test therapeutic candidates in hospitalised COVID-19 patients
Biogen signs $3.1bn deal with Sage for potential depression therapies
Zuranolone already has a breakthrough therapy designation from the US FDA
COVID-19 infections in England drop by 30% amid national lockdown
Observations come from REACT study led by Imperial College London and Ipsos MORI
Moderna and UK sign agreement for additional doses of COVID-19 vaccine
The UK has secured another two million doses on top of previously agreed five million doses
PMEA 2020: continuing to recognise excellence in improving patient outcomes
The 20th annual PMEAs took place virtually this year due to COVID-19
BMS’ Opdivo wins EU approval for second-line oesophageal cancer
Competition heats up with rival checkpoint inhibitor Keytruda
Q&A: Caroline Gosling
PME interviews Rubica's Director of Culture & Engagement
-
Q&A: Isabel GibsonPME interviews W2O ISO's Managing Director
-
Q&A: Kate Callan
-
Russia says its Sputnik V COVID-19 vaccine is 91.4% effective Preliminary data demonstrates efficacy of 95% after 42 days
-
EU buys 160 million doses of Moderna’s COVID-19 vaccineDeal follows positive data readout last week
-
Roche’s Xofluza pill wins FDA approval for post-exposure flu preventionFirst single-dose flu medication approved for post-exposure prophylaxis
-
PMEA Awards 2020Watch the event live from 4pm today – join us at www.pmlive.com/pmea2020
-
Merck submits 15-valent pneumococcal vaccine candidate to EMA and FDAIf approved, this vaccine will closely challenge Pfizer's Prevnar-13
-
Pfizer doses first patient in investigational haemophilia drug trialCompany is evaluating marstacimab in severe haemophilia A/B patients
-
WHO director-general says urgent support is needed for COVAX facility Immediate funding support totalling $4.3bn is required
Latest appointments
-
OPEN Health names Rob Barker chief executive officerBarker succeeds outgoing OPEN Health CEO and co-founder David Rowley
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm Perlmutter is set to join the board of AI drug discovery biotech Insitro
-
90TEN bolsters senior management team Agency establishes new role of head of behavioural science
-
Evoke KYNE promotes Dante DelVecchio to senior VP DelVecchio takes on the role after ten years at Evoke KYNE
-
McCann Health North America appoints Jim Joseph as president Joseph will oversee all North American advertising and promotion agencies in the US and Canada
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Senior Leader
-
Exceptionally competitive salary
- Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November
- Pfizer, Mylan move ahead with generics merger and spin-out
- PMEA 2020: continuing to recognise excellence in improving patient outcomes
- GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine
- J&J advances COVID-19 vaccine into second phase 3 trial
- PMEA Awards 2020: Results - PMEA
- Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
- AZ divests European rights for cholesterol med Crestor to Grünenthal
- Moderna eyes COVID-19 vaccine approval in the US and the EU
- AZ, Oxford University face more scrutiny over COVID-19 vaccine data
- Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda
- Winter is coming
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
- Providers are looking at digital solutions to transform this area of healthcare...
- Live webinar:
- The power of a good story: Turn your insights into effective storytelling with data visualisation...
- The important role of CROs in shaping the future of clinical research across Europe
- Looking at the impact of COVID-19 on clinical research activities...
Quick links
Infographics
